{"pmid":32340097,"title":"[Comparison of epidemiological and clinical characteristics of SARS, pandemic (H1N1) 2009 and COVID-19, and consideration on prevention and control strategies of COVID-19].","text":["[Comparison of epidemiological and clinical characteristics of SARS, pandemic (H1N1) 2009 and COVID-19, and consideration on prevention and control strategies of COVID-19].","We compared the epidemiological and clinical characteristics of severe acute respiratory syndrome (SARS), pandemic (H1N1) 2009 and COVID-19 and found that COVID-19 was more contagious, more concealed in transmission, with greater infectious intensity and more severe clinical manifestations. If the COVID-19 epidemic is not effectively controlled, it will have a serious impact on human health, and even social development. Recognizing the characteristics of three diseases, especially COVID-19, and improving the disease awareness of COVID-19 will help better implement the guidelines of \"scientific prevention and treatment, precise implementation\" and prevent and control COVID-19.","Zhonghua Yu Fang Yi Xue Za Zhi","Wang, H Q","32340097"],"abstract":["We compared the epidemiological and clinical characteristics of severe acute respiratory syndrome (SARS), pandemic (H1N1) 2009 and COVID-19 and found that COVID-19 was more contagious, more concealed in transmission, with greater infectious intensity and more severe clinical manifestations. If the COVID-19 epidemic is not effectively controlled, it will have a serious impact on human health, and even social development. Recognizing the characteristics of three diseases, especially COVID-19, and improving the disease awareness of COVID-19 will help better implement the guidelines of \"scientific prevention and treatment, precise implementation\" and prevent and control COVID-19."],"journal":"Zhonghua Yu Fang Yi Xue Za Zhi","authors":["Wang, H Q"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32340097","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.3760/cma.j.cn112150-20200403-00508","keywords":["covid-19","pandemic (h1n1) 2009","severe acute respiratory syndrome"],"topics":["Diagnosis","Prevention"],"weight":1,"_version_":1665351883821154304,"score":8.574329,"similar":[{"pmid":32331805,"title":"Echoes of 2009 H1N1 Influenza Pandemic in the COVID Pandemic.","text":["Echoes of 2009 H1N1 Influenza Pandemic in the COVID Pandemic.","The severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV2) pandemic that has engulfed the globe has had incredible effects on health care systems and economic activity. Social distancing and school closures have played a central role in public health efforts to counter the coronavirus disease 2019 (COVID)-19 pandemic. The most recent global pandemic prior to COVID-19 was the 2009 pandemic, hemagglutinin type 1 and neuraminidase type 1 (H1N1) influenza. The course of events in 2009 offer some rich lessons that could be applied to the current COVID-19 pandemic. This commentary highlights some of the most relevant points and a discussion of possible outcomes of the COVID-19 pandemic. (c) 2020 Elsevier Inc.","Clin Ther","Jhaveri, Ravi","32331805"],"abstract":["The severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV2) pandemic that has engulfed the globe has had incredible effects on health care systems and economic activity. Social distancing and school closures have played a central role in public health efforts to counter the coronavirus disease 2019 (COVID)-19 pandemic. The most recent global pandemic prior to COVID-19 was the 2009 pandemic, hemagglutinin type 1 and neuraminidase type 1 (H1N1) influenza. The course of events in 2009 offer some rich lessons that could be applied to the current COVID-19 pandemic. This commentary highlights some of the most relevant points and a discussion of possible outcomes of the COVID-19 pandemic. (c) 2020 Elsevier Inc."],"journal":"Clin Ther","authors":["Jhaveri, Ravi"],"date":"2020-04-26T11:00:00Z","year":2020,"_id":"32331805","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.clinthera.2020.04.003","keywords":["2009 pandemic h1n1","covid","sars-cov2","influenza","school closures","social distancing"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1665071049639723008,"score":156.79997},{"pmid":32224074,"pmcid":"PMC7151343","title":"Comparison of Hospitalized Patients With ARDS Caused by COVID-19 and H1N1.","text":["Comparison of Hospitalized Patients With ARDS Caused by COVID-19 and H1N1.","BACKGROUND: Since the outbreak of coronavirus disease 2019 (COVID-19) in China in December 2019, considerable attention has been focused on its elucidation. However, it is also important for clinicians and epidemiologists to differentiate COVID-19 from other respiratory infectious diseases such as influenza viruses. RESEARCH QUESTION: The aim of this study was to explore the different clinical presentations between COVID-19 and influenza A (H1N1) pneumonia in patients with ARDS. STUDY DESIGN AND METHODS: This analysis was a retrospective case-control study. Two independent cohorts of patients with ARDS infected with either COVID-19 (n = 73) or H1N1 (n = 75) were compared. Their clinical manifestations, imaging characteristics, treatments, and prognosis were analyzed and compared. RESULTS: The median age of patients with COVID-19 was higher than that of patients with H1N1, and there was a higher proportion of male subjects among the COVID-19 cohort (P < .05). Patients with COVID-19 exhibited higher proportions of nonproductive coughs, fatigue, and GI symptoms than those of patients with H1N1 (P < .05). Patients with H1N1 had higher Sequential Organ Failure Assessment (SOFA) scores than patients with COVID-19 (P < .05). The Pao2/Fio2 of 198.2 mm Hg in the COVID-19 cohort was significantly higher than the Pao2/Fio2 of 107.0 mm Hg in the H1N1 cohort (P < .001). Ground-glass opacities was more common in patients with COVID-19 than in patients with H1N1 (P < .001). There was a greater variety of antiviral therapies administered to COVID-19 patients than to H1N1 patients. The in-hospital mortality of patients with COVID-19 was 28.8%, whereas that of patients with H1N1 was 34.7% (P = .483). SOFA score-adjusted mortality of H1N1 patients was significantly higher than that of COVID-19 patients, with a rate ratio of 2.009 (95% CI, 1.563-2.583; P < .001). INTERPRETATION: There were many differences in clinical presentations between patients with ARDS infected with either COVID-19 or H1N1. Compared with H1N1 patients, patients with COVID-19-induced ARDS had lower severity of illness scores at presentation and lower SOFA score-adjusted mortality.","Chest","Tang, Xiao","Du, Ronghui","Wang, Rui","Cao, Tanze","Guan, Lulu","Yang, Chengqing","Zhu, Qi","Hu, Ming","Li, Xuyan","Li, Ying","Liang, Lirong","Tong, Zhaohui","Sun, Bing","Peng, Peng","Shi, Huanzhong","32224074"],"abstract":["BACKGROUND: Since the outbreak of coronavirus disease 2019 (COVID-19) in China in December 2019, considerable attention has been focused on its elucidation. However, it is also important for clinicians and epidemiologists to differentiate COVID-19 from other respiratory infectious diseases such as influenza viruses. RESEARCH QUESTION: The aim of this study was to explore the different clinical presentations between COVID-19 and influenza A (H1N1) pneumonia in patients with ARDS. STUDY DESIGN AND METHODS: This analysis was a retrospective case-control study. Two independent cohorts of patients with ARDS infected with either COVID-19 (n = 73) or H1N1 (n = 75) were compared. Their clinical manifestations, imaging characteristics, treatments, and prognosis were analyzed and compared. RESULTS: The median age of patients with COVID-19 was higher than that of patients with H1N1, and there was a higher proportion of male subjects among the COVID-19 cohort (P < .05). Patients with COVID-19 exhibited higher proportions of nonproductive coughs, fatigue, and GI symptoms than those of patients with H1N1 (P < .05). Patients with H1N1 had higher Sequential Organ Failure Assessment (SOFA) scores than patients with COVID-19 (P < .05). The Pao2/Fio2 of 198.2 mm Hg in the COVID-19 cohort was significantly higher than the Pao2/Fio2 of 107.0 mm Hg in the H1N1 cohort (P < .001). Ground-glass opacities was more common in patients with COVID-19 than in patients with H1N1 (P < .001). There was a greater variety of antiviral therapies administered to COVID-19 patients than to H1N1 patients. The in-hospital mortality of patients with COVID-19 was 28.8%, whereas that of patients with H1N1 was 34.7% (P = .483). SOFA score-adjusted mortality of H1N1 patients was significantly higher than that of COVID-19 patients, with a rate ratio of 2.009 (95% CI, 1.563-2.583; P < .001). INTERPRETATION: There were many differences in clinical presentations between patients with ARDS infected with either COVID-19 or H1N1. Compared with H1N1 patients, patients with COVID-19-induced ARDS had lower severity of illness scores at presentation and lower SOFA score-adjusted mortality."],"journal":"Chest","authors":["Tang, Xiao","Du, Ronghui","Wang, Rui","Cao, Tanze","Guan, Lulu","Yang, Chengqing","Zhu, Qi","Hu, Ming","Li, Xuyan","Li, Ying","Liang, Lirong","Tong, Zhaohui","Sun, Bing","Peng, Peng","Shi, Huanzhong"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32224074","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.chest.2020.03.032","keywords":["ards","covid-19","h1n1","influenza a","mortality"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640912755523586,"score":145.55006},{"pmid":32220177,"title":"[Epidemiology, Treatment, and Epidemic Prevention and Control of the Coronavirus Disease 2019: a Review].","text":["[Epidemiology, Treatment, and Epidemic Prevention and Control of the Coronavirus Disease 2019: a Review].","This review summarizes the ongoing researches regarding etiology, epidemiology, transmission dynamics, treatment, and prevention and control strategies of the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with comparison to severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and pandemic H1N1 virus. SARS-CoV-2 may be originated from bats, and the patients and asymptomatic carriers are the source of epidemic infection. The virus can be transmitted human-to-human through droplets and close contact, and people at all ages are susceptible to this virus. The main clinical symptoms of the patients are fever and cough, accompanied with leukocytopenia and lymphocytopenia. Effective drugs have been not yet available thus far. In terms of the prevention and control strategies, vaccine development as the primary prevention should be accelerated. Regarding the secondary prevention, ongoing efforts of the infected patients and close contacts quarantine, mask wearing promotion, regular disinfection in public places should be continued. Meanwhile, rapid detection kit for serological monitoring of the virus in general population is expected so as to achieve early detection, early diagnosis, early isolation and early treatment. In addition, public health education on this disease and prevention should be enhanced so as to mitigate panic and mobilize the public to jointly combat the epidemic.","Sichuan Da Xue Xue Bao Yi Xue Ban","Luan, Rong-Sheng","Wang, Xin","Sun, Xin","Chen, Xing-Shu","Zhou, Tao","Liu, Quan-Hui","Lu, Xin","Wu, Xian-Ping","Gu, Dong-Qing","Tang, Ming-Shuang","Cui, Hui-Jie","Shan, Xue-Feng","Ouyang, Jing","Zhang, Ben","Zhang, Wei","Sichuan University Covid-, Emergency Research Group","32220177"],"abstract":["This review summarizes the ongoing researches regarding etiology, epidemiology, transmission dynamics, treatment, and prevention and control strategies of the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with comparison to severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and pandemic H1N1 virus. SARS-CoV-2 may be originated from bats, and the patients and asymptomatic carriers are the source of epidemic infection. The virus can be transmitted human-to-human through droplets and close contact, and people at all ages are susceptible to this virus. The main clinical symptoms of the patients are fever and cough, accompanied with leukocytopenia and lymphocytopenia. Effective drugs have been not yet available thus far. In terms of the prevention and control strategies, vaccine development as the primary prevention should be accelerated. Regarding the secondary prevention, ongoing efforts of the infected patients and close contacts quarantine, mask wearing promotion, regular disinfection in public places should be continued. Meanwhile, rapid detection kit for serological monitoring of the virus in general population is expected so as to achieve early detection, early diagnosis, early isolation and early treatment. In addition, public health education on this disease and prevention should be enhanced so as to mitigate panic and mobilize the public to jointly combat the epidemic."],"journal":"Sichuan Da Xue Xue Bao Yi Xue Ban","authors":["Luan, Rong-Sheng","Wang, Xin","Sun, Xin","Chen, Xing-Shu","Zhou, Tao","Liu, Quan-Hui","Lu, Xin","Wu, Xian-Ping","Gu, Dong-Qing","Tang, Ming-Shuang","Cui, Hui-Jie","Shan, Xue-Feng","Ouyang, Jing","Zhang, Ben","Zhang, Wei","Sichuan University Covid-, Emergency Research Group"],"date":"2020-03-29T11:00:00Z","year":2020,"_id":"32220177","week":"202013|Mar 23 - Mar 29","doi":"10.12182/20200360505","keywords":["coronavirus disease 2019","epidemic prevention and control","epidemiology","treatment"],"source":"PubMed","topics":["Mechanism","Diagnosis","Treatment","Prevention"],"weight":1,"_version_":1664638742957129728,"score":119.60299},{"pmid":32267098,"title":"Digestive system involvement of novel coronavirus infection: prevention and control infection from a gastroenterology perspective.","text":["Digestive system involvement of novel coronavirus infection: prevention and control infection from a gastroenterology perspective.","An epidemic of an acute respiratory syndrome caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan, China, now known as coronavirus disease 2019 (COVID-19), beginning in December 2019 has attracted an intense amount of attention worldwide. As the natural history and variety of clinical presentations of this disease unfolds, the extrapulmonary symptoms of the disease have emerged, especially the symptoms related to the digestive system. While the respiratory mode of transmission is well-known and likely the principal mode of transmission of this disease, the possibility of the fecal-oral route of transmission has also emerged in various case series and clinical scenario. In this review article, we summarized the published literatures to date concerning four different aspects: (a) gastrointestinal manifestations of COVID-19 infection; (b) microbiologic and virological investigations; (c) the role of fecal-oral transmission; and (d) prevention/control infection in the digestive endoscopy room. A timely understanding of the relationship between the disease and the digestive system and implementing effective preventive measures are of great significance for a favorable outcome of the disease and can help mitigate further transmission by appropriate measures. This article is protected by copyright. All rights reserved.","J Dig Dis","Li, Lian Yong","Wu, Wei","Chen, Sheng","Gu, Jian Wen","Li, Xin Lou","Song, Hai Jing","Du, Feng","Wang, Gang","Zhong, Chang Qing","Wang, Xiao Ying","Chen, Yan","Shah, Rushikesh","Yang, He Ming","Cai, Qiang","32267098"],"abstract":["An epidemic of an acute respiratory syndrome caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan, China, now known as coronavirus disease 2019 (COVID-19), beginning in December 2019 has attracted an intense amount of attention worldwide. As the natural history and variety of clinical presentations of this disease unfolds, the extrapulmonary symptoms of the disease have emerged, especially the symptoms related to the digestive system. While the respiratory mode of transmission is well-known and likely the principal mode of transmission of this disease, the possibility of the fecal-oral route of transmission has also emerged in various case series and clinical scenario. In this review article, we summarized the published literatures to date concerning four different aspects: (a) gastrointestinal manifestations of COVID-19 infection; (b) microbiologic and virological investigations; (c) the role of fecal-oral transmission; and (d) prevention/control infection in the digestive endoscopy room. A timely understanding of the relationship between the disease and the digestive system and implementing effective preventive measures are of great significance for a favorable outcome of the disease and can help mitigate further transmission by appropriate measures. This article is protected by copyright. All rights reserved."],"journal":"J Dig Dis","authors":["Li, Lian Yong","Wu, Wei","Chen, Sheng","Gu, Jian Wen","Li, Xin Lou","Song, Hai Jing","Du, Feng","Wang, Gang","Zhong, Chang Qing","Wang, Xiao Ying","Chen, Yan","Shah, Rushikesh","Yang, He Ming","Cai, Qiang"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32267098","week":"202015|Apr 06 - Apr 12","doi":"10.1111/1751-2980.12862","keywords":["covid-19","digestive system","prevention and control","severe acute respiratory syndrome coronavirus 2"],"source":"PubMed","topics":["Transmission","Prevention","Diagnosis"],"weight":1,"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664637635969155072,"score":109.036606},{"pmid":32141570,"title":"Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.","text":["Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.","OBJECTIVE: Human infections with zoonotic coronavirus contain emerging and reemerging pathogenic characteristics which have raised great public health concern. This study aimed at investigating the global prevalence, biological and clinical characteristics of novel coronavirus, Wuhan China (2019-nCoV), Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection outbreaks. MATERIALS AND METHODS: The data on the global outbreak of \"2019-nCoV, SARS-CoV, and MERS-CoV\" were obtained from World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), concerned ministries and research institutes. We also recorded the information from research documents published in global scientific journals indexed in ISI Web of Science and research centers on the prevalence, biological and clinical characteristics of 2019-nCoV, SARS-CoV, and MERS-CoV. RESULTS: Worldwide, SARS-CoV involved 32 countries, with 8422 confirmed cases and 916 (10.87%) casualties from November 2002 to August 2003. MERS-CoV spread over 27 states, causing 2496 cases and 868 (34.77%) fatalities during the period April 2012 to December 2019. However, the novel coronavirus 2019-nCoV spread swiftly the global borders of 27 countries. It infected 34799 people and resulted in 724 (2.08%) casualties during the period December 29, 2019 to February 7, 2020. The fatality rate of coronavirus MERS-CoV was (34.77%) higher than SARS-CoV (10.87%) and 2019-nCoV (2.08%); however, the 2019-nCoV transmitted rapidly in comparison to SARS-CoV and MERS-CoV. CONCLUSIONS: The novel coronavirus 2019-nCoV has diverse epidemiological and biological characteristics, making it more contagious than SARS-CoV and MERS-CoV. It has affected more people in a short time period compared to SARS-CoV and MERS-CoV, although the fatality rate of MERS-CoV was higher than SARS-CoV and 2019-nCoV. The major clinical manifestations in coronavirus infections 2019-nCoV, MERS-CoV, and SARS CoV are fever, chills, cough, shortness of breath, generalized myalgia, malaise, drowsy, diarrhea, confusion, dyspnea, and pneumonia. Global health authorities should take immediate measures to prevent the outbreaks of such emerging and reemerging pathogens across the globe to minimize the disease burden locally and globally.","Eur Rev Med Pharmacol Sci","Meo, S A","Alhowikan, A M","Al-Khlaiwi, T","Meo, I M","Halepoto, D M","Iqbal, M","Usmani, A M","Hajjar, W","Ahmed, N","32141570"],"abstract":["OBJECTIVE: Human infections with zoonotic coronavirus contain emerging and reemerging pathogenic characteristics which have raised great public health concern. This study aimed at investigating the global prevalence, biological and clinical characteristics of novel coronavirus, Wuhan China (2019-nCoV), Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV), and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection outbreaks. MATERIALS AND METHODS: The data on the global outbreak of \"2019-nCoV, SARS-CoV, and MERS-CoV\" were obtained from World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), concerned ministries and research institutes. We also recorded the information from research documents published in global scientific journals indexed in ISI Web of Science and research centers on the prevalence, biological and clinical characteristics of 2019-nCoV, SARS-CoV, and MERS-CoV. RESULTS: Worldwide, SARS-CoV involved 32 countries, with 8422 confirmed cases and 916 (10.87%) casualties from November 2002 to August 2003. MERS-CoV spread over 27 states, causing 2496 cases and 868 (34.77%) fatalities during the period April 2012 to December 2019. However, the novel coronavirus 2019-nCoV spread swiftly the global borders of 27 countries. It infected 34799 people and resulted in 724 (2.08%) casualties during the period December 29, 2019 to February 7, 2020. The fatality rate of coronavirus MERS-CoV was (34.77%) higher than SARS-CoV (10.87%) and 2019-nCoV (2.08%); however, the 2019-nCoV transmitted rapidly in comparison to SARS-CoV and MERS-CoV. CONCLUSIONS: The novel coronavirus 2019-nCoV has diverse epidemiological and biological characteristics, making it more contagious than SARS-CoV and MERS-CoV. It has affected more people in a short time period compared to SARS-CoV and MERS-CoV, although the fatality rate of MERS-CoV was higher than SARS-CoV and 2019-nCoV. The major clinical manifestations in coronavirus infections 2019-nCoV, MERS-CoV, and SARS CoV are fever, chills, cough, shortness of breath, generalized myalgia, malaise, drowsy, diarrhea, confusion, dyspnea, and pneumonia. Global health authorities should take immediate measures to prevent the outbreaks of such emerging and reemerging pathogens across the globe to minimize the disease burden locally and globally."],"journal":"Eur Rev Med Pharmacol Sci","authors":["Meo, S A","Alhowikan, A M","Al-Khlaiwi, T","Meo, I M","Halepoto, D M","Iqbal, M","Usmani, A M","Hajjar, W","Ahmed, N"],"date":"2020-03-07T11:00:00Z","year":2020,"_id":"32141570","week":"202010|Mar 02 - Mar 08","doi":"10.26355/eurrev_202002_20379","source":"PubMed","topics":["Mechanism","Prevention"],"weight":1,"locations":["Wuhan","China","diarrhea"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640874928144385,"score":103.04358}]}